Drug Store News - Schering-Plough - losses appeal over Claritin generics - Brief Article
Thursday, November 13th, 2008Schering-Plough earlier this month lost its appeal of a U.S. court decision that found generic equivalents to the company’s Claritin (loratadine) drug were not in violation of patents protecting Clarinex (desloratadine).
Most Popular
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
13 Job In…
